ArticleWorld journal of clinical cases2021

Pembrolizumab as a novel therapeutic option for patients with refractory thymic epithelial tumor: A case report.

Jonathan Wong-Chong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.